Base-Editing Gene Therapy Shows Promise in Sickle Cell Disease

(MedPage Today) -- Treatment with the investigational base-editing gene therapy ristoglogene autogetemcel (risto-cel) showed promise in patients with sickle cell disease, according to an interim analysis of the phase I/II BEACON study. Neutrophil...
Source
MedPage Today
Opens original article in a new tab



